H eart failure remains the leading cause of death in the industrialized countries and represents the emerging epidemics of the third millennium. 1 In ischemic and idiopathic dilated cardiomyopathies, in addition to extensive myocardial scarring and despite huge myocyte hypertrophy, a disproportion has been found between myocardial growth and left ventricular (LV) chamber enlargement, leading to a significant reduction in myocardial mass-to-chamber volume ratio. [2] [3] [4] [5] [6] Hypertension, myocardial hypertrophy, and ischemia accelerate the physiological drop-off of cardiomyocytes occurring with age, 3, 4, [7] [8] [9] and it can be assumed that cardiac dysfunction and failure may supervene when the number of remaining viable hypertrophied cells is too low to maintain cardiac performance. The mechanisms that provoke the ongoing myocyte loss remain unknown. Endocrine and paracrine factors, including catecholamines and angiotensin II (Ang II), may cause myocyte hypertrophy and myocyte death through apoptosis and necrosis. 10 -15 
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Furthermore, the presence and functional relevance of a kallikrein-kinin system in the heart are firmly established 16 -19 Kinins, cleaved by kallikrein from substrate kininogen, stimulate the release of NO and prostacyclin through the activation of bradykinin (BK) B 2 receptors. This action opposes Ang II-induced vasoconstriction and exerts anti-ischemic, antiproliferative, and antiatherosclerotic effects, preserving myocardial stores of energy-rich phosphates and glycogen. 16,20 -24 Conversely, a dysfunctional kallikrein-kinin system may contribute to the pathogenesis of heart failure. In fact, reduced local kinin generation and blunted NO formation have been reported in failing human hearts. 20 Furthermore, icatibant, a selective antagonist of the BK B 2 receptor, reduces coronary blood flow and contractility and increases LV end-diastolic pressure in pacing-induced heart failure. 25 Thus, to test the hypothesis that the absence of the BK B 2 receptor may lead to cardiac dysfunction, we examined the func-tional and structural changes occurring in the hearts of BK B 2 receptor knockout mice (B 2 Ϫ/Ϫ ) during development. This genetic model has similarity with the natural history of patients with hypertension and ventricular hypertrophy, who are at high risk for cardiovascular complications and death. 26 -28 The informative potential of heterozygous mice (B 2 ϩ/Ϫ ), resembling a condition of partial deficiency, has been added to test whether a gene-dose effect on the cardiovascular phenotype may be present.
Methods
All procedures complied with the standards for the care and use of animal subjects as stated in the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, National Academy of Sciences, Bethesda, Md).
B 2 Ϫ/Ϫ mice were kindly provided by Dr. Fred Hess (Merck Laboratories), and wild-type control animals (B 2 ϩ/ϩ ) were obtained from Jackson Laboratories. B 2 ϩ/Ϫ mice were derived through the mating of B 2 ϩ/ϩ and B 2 Ϫ/Ϫ . Two days after birth, the sex of the pups from B 2 Ϫ/Ϫ , B 2 ϩ/ϩ , and B 2 ϩ/Ϫ groups was determined, and each litter was culled to 5 male pups. The animals were identified and housed at a constant room temperature (24Ϯ1°C) and humidity (60Ϯ3%).
Hemodynamic Measurements
Body weight (BW), systolic blood pressure (SBP), and heart rate (HR) of unanesthetized B 2 ϩ/ϩ (nϭ33), B 2 ϩ/Ϫ (nϭ12), and B 2 Ϫ/Ϫ (nϭ38) mice were measured from 40 to 360 days of age with the use of tail-cuff plethysmography. 27 At the end of the experiments, in unanesthetized mice, mean blood pressure was measured with the use of an intra-aortic catheter (PE-10; Clay Adams) with a Statham transducer (Gould). In six anesthetized mice (2,2,2-tribromoethanol, 88 mmol/100 g body wt IP; Sigma Chemical Co) of each group, LV pressure and dP/dt at 40 mm Hg were measured with a highsensitivity pressure transducer (World Precision Instruments) in a closed-chest preparation.
Heart Morphology
In B 2 ϩ/ϩ , B 2 ϩ/Ϫ , and B 2 Ϫ/Ϫ mice at 40 (nϭ23, 28, and 20, respectively), 180 (nϭ10, 16, and 18, respectively), and 360 days of age (nϭ5, 5, and 7, respectively), hearts were arrested in diastole with cadmium chloride (100 nmol), excised from blood vessels, dissected free, rinsed in saline, blotted, weighed, and fixed in 10% buffered formalin. Lung wet weight was also determined (nϭ6 each group).
Ventricular Wall and Chamber Diameter Measurements
The free walls of the right ventricle (RV) and the LV, including the septum, were dissected free, and their weights were recorded. Myocardial volume was calculated by dividing its weight by the specific gravity of muscle tissue (ie, 1.06 g/mL). The major cavitary axis of the LV from the apex to the aortic valve was measured under a stereo microscope (Wild M 600) with a calibrated ocular accurate to 0.1 mm. Transverse chamber diameters and LV wall thickness were determined with an analyzer (Image Pro Plus 3.0; accuracy 0.01 mm) with images acquired with a videocamera (Sony) through the stereo microscope (magnification ϫ16). The cavitary volume was computed with use of the Dodge equation. 29 
Analysis of Ventricular Fibrosis
Transverse slices were embedded in paraffin, and 5-m-thick sections were cut and stained with Masson's trichrome. Sections were examined at a calibrated magnification of ϫ100 with an ocular reticle containing 42 sampling points (Wild Heerbrugg Instruments). This reticle defines a sectional area of 0.85 m 2 . The points overlying the foci of perivascular or reparative fibrosis were counted separately to compute the volume fraction of myocardial fibrosis.
Myocyte Transverse Diameter and Sarcomere Length
The transverse diameter of longitudinally oriented myocytes of the LV was measured at the level of the nucleus at a magnification of ϫ1000. One hundred measurements were collected in each LV. At the same magnification, the lengths of Ն10 sarcomeres were evaluated, for a total of 200 measurements. 
Reverse-Transcription Polymerase Chain Reaction Analysis
Total RNA was isolated from frozen hearts (nϭ3 each group) according to the RNAzol B method. cDNA was made from total RNA according to the manufacturer's instructions (Stratagene).
The primers for amplification of a 157-bp product of the ␣-skeletal actin transcript were ␣-actin L (5Ј-GCT CTC TCT CCT CAG GAC C-3Ј) and ␣-actin R (5Ј-GGA GCA AAA CAG AAT GGC TGG C-3Ј). These primers are specific to the 3Ј untranslated region of ␣-actin RNA. Polymerase chain reaction amplification was performed under the following conditions: denaturing for 1 minute at 94°C, annealing for 1 minute at 61°C, and elongation for 1 minute at 72°C for 35 cycles. The primers used for amplification of a 287-bp product of angiotensin AT 1a receptor isoform were AT 1a L (GAT AAT TAT GGC GAT TGT GC) and AT 1a R (TGC TCA TTT TCG TAG ACA GG). For amplification of a 303-bp product of angiotensin AT 1b receptor isoform, the primers were AT 1b L (ATT CAG TTT TCT GGA TGT GC) and AT 1b R (TCC ACT TCA AAA CAA TAC GC). For both sets of primers, the conditions were denaturation at 95°C, annealing at 56°C, and elongation at 72°C for 30 cycles. RNA levels were normalized through amplification of glyceraldehyde-3-phosphate dehydrogenase.
Biochemical Assays
To determine the myocardial adenylate concentration, hearts (B 2 ϩ/ϩ , nϭ6; B 2 ϩ/Ϫ , nϭ6; and B 2 Ϫ/Ϫ , nϭ9) were washed in saline, frozen, and then stored at Ϫ80°C until assay. Pulverized samples were suspended in 60% methanol (in 100 mmol/L Tris ⅐ HCl buffer), homogenized, and then centrifuged for 20 minutes at 10 000g. The supernatant was dried, resuspended in 25 L of ultrapure water, and analyzed with capillary electrophoresis (P/ACE 2100 System; Beckman Instruments). Protein concentration was determined according to Lowry et al. 30 Plasma concentration of atrial natriuretic factor and endothelin-1 (ET-1) was determined (nϭ6 each group) with the use of radioimmunoassays (Phoenix) after extraction of the peptides with Sep-Pack C-18 Cartridges (Waters).
Statistical Analysis
Data are expressed as meanϮSEM. Multivariate repeated measures ANOVA was performed to test for interaction between time and grouping factor. In multiple comparisons among independent groups in which ANOVA and F test indicated significant differences, the statistical value was determined according to the Bonferroni method. Differences within and between groups were determined with paired or unpaired Student's t tests, respectively. A P value of Ͻ0.05 was considered statistically significant.
Results

Hemodynamic Measurements
The SBP of B 2 Ϫ/Ϫ mice was normal at 50 days of age and gradually increased, reaching a plateau at 6 months ( Figure  1A ). In B 2 ϩ/Ϫ mice, SBP elevation was delayed and matched the hypertensive levels of B 2 Ϫ/Ϫ mice after 6 months of age. Intra-arterial measurements confirmed the elevated BP of 
Heart Morphology
Cross sections of the hearts of knockout and wild-type mice are shown in Figure 2 . Due to a differential growth rate (Table) , at 180 days, the LV weight (LVW) of B 2 Ϫ/Ϫ and B 2 ϩ/Ϫ mice was 51% and 29% higher than that of B 2 ϩ/ϩ mice (PϽ0.01); at 360 days, however, no significant difference was detected among groups. A similar pattern was observed in RV weight (RVW). The early acceleration in LV growth of B 2 Ϫ/Ϫ mice was confirmed after normalization by body weight (BW): at 180 days, the LVW/BW ratio was 13% (PϽ0.01) and 28% (PϽ0.001) higher than that of B 2 ϩ/Ϫ and B 2 ϩ/ϩ mice, respectively ( Figure 3A ). In the second interval, a 2.2-fold increase was seen only in B 2 ϩ/Ϫ mice (PϽ0.05). Thus, at 360 days, the LV/BW ratio was 9% higher in B 2 Ϫ/Ϫ and 17% higher in B 2 ϩ/Ϫ than in B 2 ϩ/ϩ mice. No difference in RVW/BW ratio was observed among groups with maturation ( Figure 3B) . At 360 days, lung weight was greater in B 2 Ϫ/Ϫ 
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Heart Failure and Bradykininthan in B 2 ϩ/ϩ mice (7.97Ϯ0.53 versus 5.49Ϯ0.21 mg/g body wt, PϽ0.002)
A conspicuous increase in LV transverse chamber diameter occurred in B 2 Ϫ/Ϫ mice (1.8-fold), equally distributed in the 2 intervals ( Figure 4A ). This increase was greater (PϽ0.05) than that of B 2 ϩ/ϩ or B 2 ϩ/Ϫ mice (1.4-and 1.5-fold, respectively). A slight elongation in LV chamber length was observed in both B 2 ϩ/ϩ and B 2 Ϫ/Ϫ mice, with no further change later ( Figure 4B ). As a result of the changes in these linear dimensions, a 4.0-fold enlargement of LV chamber was found in B 2 Ϫ/Ϫ mice compared with 2.6-and 2.3-fold increases in B 2 ϩ/Ϫ and B 2 Ϫ/Ϫ mice, respectively (PϽ0.001 for both comparisons).
At variance with the compensatory remodeling found in heterozygous mice, in B 2 Ϫ/Ϫ mice, the growth in wall thickness and myocardial mass was inadequate to compensate chamber enlargement (Table) . In fact, at 360 days, the ratio of mass to chamber volume for knockout mice was 27% (PϽ0.01) and 24% (PϽ0.05) lower than that for B 2 ϩ/ϩ and B 2 ϩ/Ϫ mice, respectively ( Figures 4C and 4D ). Diastolic LV wall stress, calculated from hemodynamic and anatomic data, was 114% higher in B 2 Ϫ/Ϫ mice than in B 2 ϩ/ϩ mice at 180 days (54Ϯ9 versus 25Ϯ6 dynes/mm 2 ; PϽ0.001), and at 360 days, it reached 126Ϯ15 dynes/mm 2 , a value 655% higher (PϽ0.001) than that of B 2 ϩ/ϩ mice (17Ϯ8 dynes/mm 2 ).
As shown in the Table, at 360 days, the myocytes of B 2 ϩ/Ϫ and B 2 Ϫ/Ϫ mice were 17% and 15% thinner than those of B 2 ϩ/ϩ mice (PϽ0.05 for both comparisons). Sarcomere length was similar among groups at all ages examined.
At 40 days, the structure of ventricular myocardium did not reveal pathological alterations in any group. Later, distinct foci of fibrosis were present in the LV, mainly in the subendocardium but also scattered throughout the wall ( Figure 5 ). Compared with B 2 ϩ/ϩ mice ( Figure 6 ), B 2 Ϫ/Ϫ mice showed an increase in perivascular and reparative fibrosis at 180 days (178% and 930%, respectively, PϽ0.05) and an even greater increase at 360 days (1013% and 1397%, respectively, PϽ0.01). No reparative fibrosis was seen in the RV.
Gene Expression in Heart
At 40 days, the mRNA levels of ␣-skeletal actin were 8.0-and 4.1-fold greater in the hearts of B 2 Ϫ/Ϫ and B 2 ϩ/Ϫ , respectively, than B 2 ϩ/ϩ mice ( Figure 7 ). This pattern persisted in adult animals. By contrast, the expression of AT 1 receptor isoforms was similar among groups at all ages examined (data not shown). ϩ/ϩ , respectively). At the same age, plasma concentrations of ANF were increased in B 2 Ϫ/Ϫ mice (222Ϯ46 versus 18Ϯ11 pg/mL in B 2 ϩ/ϩ , PϽ0.05), whereas no group difference was detected regarding circulating ET-1 levels (3.34Ϯ1.31 versus 4.15Ϯ0.87 pg/mL, PϭNS).
Biochemical Assays
Discussion
The relevance of kinins in the regulation of BP has been described repeatedly. 31, 32 In particular, the importance of the BK B 2 receptor has been demonstrated in genetically modified murine models. Transgenic mice in which the human B 2 receptor gene has been added to the murine gene are hypotensive, 33 whereas B 2 Ϫ/Ϫ mice have mildly elevated BP levels. 27 Furthermore, B 2 ϩ/Ϫ mice, which mimic a condition of partial deficiency, are normotensive until 5 months of age, 27 but with maturation, as demonstrated here, they show a delayed progressive elevation of BP. These data indicate that genetically determined changes in the level of expression of the BK B 2 receptor directly affect the BP of mice during development.
The tachycardia observed in B 2
Ϫ/Ϫ
, similar to that found in rats with prenatal blockade of the BK B 2 receptor, 34 confirms that kinins are involved in the early programming of the cardiovascular phenotype. Because norepinephrine release is diminished in B 2 Ϫ/Ϫ mice, 35 the elevated basal HR might be the consequence of sensitization of sinoatrial ␤-adrenoceptors to catecholamines. Other possible explanations include perturbation in the activity of intrinsic cardiac cholinergic neurons, 36 perturbation of transduction mechanisms linked to ␤-adrenoceptors, and alteration in the central baroreflex control of HR. 37, 38 It appears likely that Ang II contributes to the development of cardiac remodeling in mice with partial or total deficiency of the BK B 2 receptor. The results of our previous studies demonstrated that in B 2 Ϫ/Ϫ mice, the interrupted receptor signaling leads to blunted basal activation of NO pathway, leaving unbalanced Ang II-induced vasoconstriction. 27 However, the elevation in BP was only moderate in B 2 Ϫ/Ϫ mice, and a load-independent mechanism may be operative. 39 The observation that myocardial hypertrophy was present in heterozygous mice at 180 days, when BP was just starting to diverge from normal, is consistent with this hypothesis. In addition, reactivation of fetal ␣-skeletal actin expression (an immediate-early gene response reportedly induced by Ang II independent of its vasoconstrictor action) 40, 41 in the heart of B 2 Ϫ/Ϫ mice precedes any increase in BP. The counterregulatory influence of kinins on Ang II-induced myocardial growth has been documented in animal models with renin-dependent hypertension 42, 43 and in in vitro preparations of cardiomyocytes cocultured with endothelial cells. 44 Consistently, we found that early, lifelong administration of an AT 1 receptor antagonist prevents myocardial hypertrophy and fibrosis in B 2 Ϫ/Ϫ mice while only temporarily blunting the tendency to develop hypertension (Paolo Madeddu, unpublished results, 1999). Interestingly, plasma renin activity and cardiac expression of the renin gene are not altered in B 2 Ϫ/Ϫ mice at 6 months, 27 and as demonstrated here, AT 1 receptor expression is also unaffected by the mutation even at later stages of the life. ET-1 is well known to play a role in myocyte growth, 45 and the formation of ET-1 can be inhibited with BK via the B 2 receptor. 46 However, we found that circulating levels of ET-1 are normal in B 2 Ϫ/Ϫ mice. The development of ventricular dysfunction and failure in this knockout model is documented by anatomic, functional, and biochemical data. Combined, these abnormalities simulate the characteristic findings of decompensated cardiac hypertrophy seen in humans. 47 In accordance with Laplace's law, the hearts of B 2 Ϫ/Ϫ mice are exposed to a substantial increase in the diastolic circumferential wall stress. It should be pointed out, however, that computed data may underestimate the stress on a per-cell basis due to the amount of myocyte replaced by reparative fibrosis. The distribution of myocardial fibrosis mainly in the subendocardium, the layer most exposed to the increased intraventricular diastolic pressure, again seems to confirm the importance of mechanical factors in the development of heart failure in this model. The decrease in myocardial adenylate content suggests an intrinsic alteration in energy buildup in the failing hearts of B 2 Ϫ/Ϫ mice. A shortage of myocardial energy reserves might have exaggerated the consequences of the pressure overload on the heart, leading to an abnormal growth response and accelerated myocyte death. A gene-dose effect influenced the severity of myocardial changes in mutant animals. Heterozygosity, in fact, was characterized by proportional increases in chamber volume and myocardial mass without cardiac dysfunction.
In conclusion, our results indicate that a partial deficiency of the BK B 2 receptor causes LV hypertrophy and that total deficiency induces decompensated hypertrophy and failure similar to the hypertrophic hypertensive cardiomyopathy seen in humans, demonstrating the essential role of kinins in the preservation of myocardial structure and function.
Note Added in Proof
After the accpetance of this article, on the occasion of the 53rd Annual Fall Conference of the Council for High Blood Pressure Research, Pierra Meneton et al showed that disruption of tissue kallikrein gene triggers dilated cardiomyopathy in mice (Meneton P, Block-Favre M, Hagege A, Gasc JM, Huang W, Neubauer M, Duffy J, Menard J, Alhenc-Galas F. Targeted disruption of the tissue kallikrien gene triggers cardiac abnormalities typical of a dilated cardiomyopathy. Hypertension. 1999;34:333. Abstract.) These data reinforce the view that the kallikrein kinin system is important for normal heart maturation. 
